CNO Financial Group (CNO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Achieved strong financial and operational results in 2025, with net income of $229.3 million and net operating income of $439.2 million, driven by sales growth, improved margins, and disciplined expense management.
Returned $386.1 million to shareholders through share repurchases and dividends, reducing share count by 8% and maintaining robust capital and liquidity positions.
Continued strategic transformation, including exiting Worksite fee services and focusing on core insurance business, while maintaining a diversified distribution model.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors for one-year terms, a non-binding advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Proxy access and advance notice provisions are in place for shareholder proposals and director nominations for future meetings.
Board of directors and corporate governance
Board comprises 90% independent directors, with diverse backgrounds in gender, ethnicity, and professional experience.
Five board committees oversee audit, governance, compensation, investment, and executive matters, each with defined charters and responsibilities.
Regular board refreshment and succession planning, with five new directors in the past five years and robust onboarding and evaluation processes.
Board leadership structure features an independent chair, separate from the CEO.
Latest events from CNO Financial Group
- Operating EPS up 94%, guidance raised, and sales and investment income surged in Q2 2024.CNO
Q2 20249 Jul 2026 - EPS up 26% with record annuity sales, raised 2024 guidance, and strong capital returns.CNO
Q3 20249 Jul 2026 - Record new annualized premiums and 11% EPS growth drove robust 2025 results.CNO
Q4 20258 Jul 2026 - Record sales, earnings growth, and capital returns drive strong 2024 results and 2025 outlook.CNO
Q4 20248 Jul 2026 - All proposals passed and strong financial growth highlighted, with focus on future ROE gains.CNO
AGM 202615 May 2026 - Operating EPS up 33%, net income up, and premiums up 11% with strong capital and outlook.CNO
Q1 20267 May 2026 - Annual meeting covers director elections, executive pay, auditor ratification, and ESG efforts.CNO
Proxy filing26 Mar 2026 - Growth momentum driven by middle market focus, agent productivity, and operational efficiency.CNO
2024 KBW Insurance Conference22 Jan 2026 - Operating EPS up 52%, guidance reaffirmed, and capital strength and buybacks continued.CNO
Q1 202524 Dec 2025